Skip to main content
Erschienen in: Current Rheumatology Reports 2/2012

01.04.2012 | PEDIATRIC RHEUMATOLOGY (TJA LEHMAN, SECTION EDITOR)

The Clinical Spectrum of Juvenile Idiopathic Arthritis in a Large Urban Population

verfasst von: Melissa S. Tesher, Karen B. Onel

Erschienen in: Current Rheumatology Reports | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Urban populations present particular challenges for medical providers. Patients are extremely diverse, with varied socioeconomic, cultural, and ethnic backgrounds. Physicians caring for children with juvenile idiopathic arthritis must be prepared to interact effectively with many types of families who bring with them varied experiences and expectations. Pediatric rheumatologists should be familiar with patient characteristics that can influence disease outcomes. Access to care is affected by place of residence, referral delays, parental education, and the child’s insurance status. Patients of different ethnic backgrounds vary in their trust of physicians and health systems. Understanding of risk in medical decision making is influenced by ethnicity as well. Adherence also varies by ethnic group, with African American patients reporting lower adherence than Caucasian patients. Issues of doctor–patient communication and use of complementary and alternative medicine are also affected by cultural factors. Especially for physicians working in a large metropolitan area, an understanding of societal factors influencing patient behavior is essential to provide optimal care for children with juvenile idiopathic arthritis.
Literatur
1.
Zurück zum Zitat Petty RE, Cassidy JT. Chronic arthritis in childhood. In: Cassidy, Petty, Laxer, Lindsley, editors. Textbook of pediatric rheumatology, 6th edn. Philadelphia. 2011. Petty RE, Cassidy JT. Chronic arthritis in childhood. In: Cassidy, Petty, Laxer, Lindsley, editors. Textbook of pediatric rheumatology, 6th edn. Philadelphia. 2011.
2.
Zurück zum Zitat Engel GL. The clinical application of the biopsychosocial model. Am J Psychiatry. 1980;137:535–44.PubMed Engel GL. The clinical application of the biopsychosocial model. Am J Psychiatry. 1980;137:535–44.PubMed
7.
Zurück zum Zitat Emery P, et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in early, moderate to severe rheumatoid arthritis (COMET): a randomized, double-blind, parallel treatment trial. Lancet. 2008;372:375–82.PubMedCrossRef Emery P, et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in early, moderate to severe rheumatoid arthritis (COMET): a randomized, double-blind, parallel treatment trial. Lancet. 2008;372:375–82.PubMedCrossRef
8.
Zurück zum Zitat Breedveld C, et al. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum. 2006;54:26–37.PubMedCrossRef Breedveld C, et al. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum. 2006;54:26–37.PubMedCrossRef
9.
Zurück zum Zitat Tynjala P, et al. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomized open-label clinical trial. Ann Rheum Dis. 2011;70:1605–12.PubMedCrossRef Tynjala P, et al. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomized open-label clinical trial. Ann Rheum Dis. 2011;70:1605–12.PubMedCrossRef
10.
Zurück zum Zitat Magnani A, et al. Achievement of a state of inactive disease at least once in the first 5 years predicts better outcome of patients with polyarticular juvenile idiopathic arthritis. J Rheumatol. 2009;36:628–34.PubMedCrossRef Magnani A, et al. Achievement of a state of inactive disease at least once in the first 5 years predicts better outcome of patients with polyarticular juvenile idiopathic arthritis. J Rheumatol. 2009;36:628–34.PubMedCrossRef
11.
Zurück zum Zitat Tzabarichev N, et al. Predictors of delayed referral to a pediatric rheumatology center. Arthritis Care Res. 2009;61:1367–72.CrossRef Tzabarichev N, et al. Predictors of delayed referral to a pediatric rheumatology center. Arthritis Care Res. 2009;61:1367–72.CrossRef
12.
Zurück zum Zitat Foster HE, et al. Delay in access to appropriate care for children presenting with musculoskeletal symptoms and ultimately diagnosed with juvenile idiopathic arthritis. Arthritis Care Res. 2007;57:921–7.CrossRef Foster HE, et al. Delay in access to appropriate care for children presenting with musculoskeletal symptoms and ultimately diagnosed with juvenile idiopathic arthritis. Arthritis Care Res. 2007;57:921–7.CrossRef
13.
Zurück zum Zitat Shiff NJ, et al. Factors associated with a longer time to access pediatric rheumatologists in Canadian children with juvenile idiopathic arthritis. J Rheumatol. 2010;37:2415–21.PubMedCrossRef Shiff NJ, et al. Factors associated with a longer time to access pediatric rheumatologists in Canadian children with juvenile idiopathic arthritis. J Rheumatol. 2010;37:2415–21.PubMedCrossRef
14.
Zurück zum Zitat • Bisgaier J, Rhodes K. Auditing access to specialty care for children with public insurance. N Engl J Med. 2011;364:2324–33. Children with public insurance have starkly reduced access to pediatric subspecialty care. Many offices will not schedule a publicly insured child at all. Even in offices that accept public insurance, publicly insured patients must wait longer to be evaluated. PubMedCrossRef • Bisgaier J, Rhodes K. Auditing access to specialty care for children with public insurance. N Engl J Med. 2011;364:2324–33. Children with public insurance have starkly reduced access to pediatric subspecialty care. Many offices will not schedule a publicly insured child at all. Even in offices that accept public insurance, publicly insured patients must wait longer to be evaluated. PubMedCrossRef
15.
Zurück zum Zitat Bruce B, Fries JF, Murtagh KN. Health status disparities in ethnic minority patients with rheumatoid arthritis: a cross-sectional study. J Rheumatol. 2007;34:1475–9.PubMed Bruce B, Fries JF, Murtagh KN. Health status disparities in ethnic minority patients with rheumatoid arthritis: a cross-sectional study. J Rheumatol. 2007;34:1475–9.PubMed
16.
Zurück zum Zitat Ang D, et al. Patient’s ethnicity does not influence utilization of effective therapies in rheumatoid arthritis. J Rheumatol. 2006;33:870–8.PubMed Ang D, et al. Patient’s ethnicity does not influence utilization of effective therapies in rheumatoid arthritis. J Rheumatol. 2006;33:870–8.PubMed
17.
Zurück zum Zitat Brunner HI, et al. Differences in disease outcomes between Medicaid and privately insured children: possible health disparities in juvenile rheumatoid arthritis. Arthritis Rheum. 2006;55:378–84.PubMedCrossRef Brunner HI, et al. Differences in disease outcomes between Medicaid and privately insured children: possible health disparities in juvenile rheumatoid arthritis. Arthritis Rheum. 2006;55:378–84.PubMedCrossRef
18.
Zurück zum Zitat Levey E, et al. Health literacy in childhood arthritis (abstract). Arthritis Rheum. 2009;60 Suppl 10:716. Levey E, et al. Health literacy in childhood arthritis (abstract). Arthritis Rheum. 2009;60 Suppl 10:716.
19.
Zurück zum Zitat Feldman DE, et al. Factors associated with the use of complementary and alternative medicine in juvenile idiopathic arthritis. Arthritis Rheum (Arthritis Care Res). 2004;51:527–32.CrossRef Feldman DE, et al. Factors associated with the use of complementary and alternative medicine in juvenile idiopathic arthritis. Arthritis Rheum (Arthritis Care Res). 2004;51:527–32.CrossRef
20.
Zurück zum Zitat Zaman T, Agarwal S, Handa R. Complementary and alternative medicine use in rheumatoid arthritis: an audit of patients visiting a tertiary care center. Natl Med J India. 2007;20:236–9.PubMed Zaman T, Agarwal S, Handa R. Complementary and alternative medicine use in rheumatoid arthritis: an audit of patients visiting a tertiary care center. Natl Med J India. 2007;20:236–9.PubMed
21.
Zurück zum Zitat Lee MS, et al. Use of complementary and alternative medicine by rheumatoid arthritis patients in Korea. Clin Rheumatol. 2008;27:29–33.PubMedCrossRef Lee MS, et al. Use of complementary and alternative medicine by rheumatoid arthritis patients in Korea. Clin Rheumatol. 2008;27:29–33.PubMedCrossRef
22.
Zurück zum Zitat Zebracki K, et al. Brief report: use of complementary and alternative medicine and psychological functioning in Latino children with juvenile idiopathic arthritis or arthralgias. J Pediatr Psychol. 2007;32:1006–10.PubMedCrossRef Zebracki K, et al. Brief report: use of complementary and alternative medicine and psychological functioning in Latino children with juvenile idiopathic arthritis or arthralgias. J Pediatr Psychol. 2007;32:1006–10.PubMedCrossRef
23.
Zurück zum Zitat Garcia-Gonzalez A, et al. Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol. 2008;27:883–9.PubMedCrossRef Garcia-Gonzalez A, et al. Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol. 2008;27:883–9.PubMedCrossRef
24.
Zurück zum Zitat Berrios-Rivera, et al. Trust in physicians and elements of the medical interaction in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res. 2006;55:385–93.CrossRef Berrios-Rivera, et al. Trust in physicians and elements of the medical interaction in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res. 2006;55:385–93.CrossRef
25.
Zurück zum Zitat • Constantinescu F, et al. Racial disparities in treatment preferences for rheumatoid arthritis. Medical Care. 2009;47:350–5. Medical decision making is notably different in African Americans compared with Caucasians. African Americans are far more risk averse and are particularly affected by increased risks of cancer due to treatments. PubMedCrossRef • Constantinescu F, et al. Racial disparities in treatment preferences for rheumatoid arthritis. Medical Care. 2009;47:350–5. Medical decision making is notably different in African Americans compared with Caucasians. African Americans are far more risk averse and are particularly affected by increased risks of cancer due to treatments. PubMedCrossRef
26.
Zurück zum Zitat Constantinescu F, et al. Understanding why rheumatoid arthritis patient treatment preferences differ by race. Arthritis Care Res. 2009;61:413–8.CrossRef Constantinescu F, et al. Understanding why rheumatoid arthritis patient treatment preferences differ by race. Arthritis Care Res. 2009;61:413–8.CrossRef
Metadaten
Titel
The Clinical Spectrum of Juvenile Idiopathic Arthritis in a Large Urban Population
verfasst von
Melissa S. Tesher
Karen B. Onel
Publikationsdatum
01.04.2012
Verlag
Current Science Inc.
Erschienen in
Current Rheumatology Reports / Ausgabe 2/2012
Print ISSN: 1523-3774
Elektronische ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-012-0237-7

Weitere Artikel der Ausgabe 2/2012

Current Rheumatology Reports 2/2012 Zur Ausgabe

CRYSTAL ARTHRITIS (MH PILLINGER, SECTION EDITOR)

Gout and Organ Transplantation

CRYSTAL ARTHRITIS (MH PILLINGER, SECTION EDITOR)

Axial (Spinal) Gout

CRYSTAL ARTHRITIS (MH PILLINGER, SECTION EDITOR)

The Patient’s Experience of Gout: New Insights to Optimize Management

PEDIATRIC RHEUMATOLOGY (TJA LEHMAN, SECTION EDITOR)

Granulomatosis with Polyangiitis in Childhood

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.